Biricodar or incel (INN, codename VX-710) was a pharmaceutical drug under development by Vertex Pharmaceuticals to help treat ovarian cancer patients, that never reached the market. External links Article on development Status of Vertex development PSLgroup article AARC article about the drug Antineoplastic drugs